Global Bioenergies today announces the start of a 3-year project to demonstrate a new value chain combining its Isobutene process with technologies developed by Sekab and Neste Engineering (...)
Articles similaires sur : "2018"
Global Bioenergies (Euronext Growth : ALGBE) announces today having been selected in three additional Horizon 2020 projects funded by the European Union, and will receive for this purpose about (...)
Genopole - France’s leading biocluster - is a dynamic ecosystem where public and private synergies are cultivated to yield tomorrow’s scientific and industrial breakthroughs in biotech. This (...)
At BIO Boston, the biocluster Genopole will encourage young French and international companies as well as young graduates with innovative biotech projects to apply for the third intake of its (...)
PARIS, France, 7:30 am (CET), October 16, 2018 – Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based (...)
ENTEROME SA, a clinical-stage biotech company developing innovative therapies to treat microbiome-associated diseases with a focus on auto-immune disease and cancer, has entered into a (...)
Genopole, the biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. This is the first time a member (...)